Learn how to navigate through the complexities and policy changes that biotech and nanotech products face today. Expert advice and case studies will provide valuable lessons on how policy and regulation is influencing technology in the US and EU and what companies can do to save time and cost throughout the process.

The debut of UNAM Ensenada’s Center for Nanoscience and Nanotechnology marks the trend of newly inaugurated departments focused on nanotechnology in universities around the world. UNAM is already recognized as the university with the highest concentration of researchers working on nanotechnology and some of the most ambitious projects. At UNAM Ensenada this announcement ties into an overall vision for the region that includes vinculation, innovation and economic sustainability through industrial applications of breakthrough technology.

Join us for holiday cheer and a unique opportunity to feed your mind and your soul with a two-part holiday extravaganza. First the NanoTumor Center will host a nanotech forum with exciting speakers (see below). Immediately following, celebrate the holidays with fine food, festive beverages and a special preview exhibit and sale of NanoArt hosted by world renowned Cris Orfescu. A portion of the proceeds will support NBN outreach programs. Also join us in the spirit of giving and support the “Toys for Tot” toy drive by bringing a new unwrapped toy. The celebration starts at 6pm. Custom chemistry and nanofabrication is essential to a wide range of biomedical applications that require binding of enzymes, antibodies, or cells to micro or nanofabricated materials. Bringing these biomedical applications to market present its own set of challenges. Join us to learn how fabrication and commercialization challenges are being addressed by experts dedicated to making these novel applications a reality. The speaker presentations start at 4:30pm.

There is increased attention and significant research in the design and synthesis of new biocompatible materials for tissue engineering, tissue regeneration and new therapeutic methods to restore the anatomic structure and function of damaged, injured or missing tissue. Join us and learn about the progress and findings in this exciting area of material science and where we stand in our understanding of molecular interactions between materials and organisms.

Join us for our premier event of the year as we celebrate another year of achievement while recognizing the thought leaders that have supported the organization. More details.

Although humans have been exposed to airborne nanoparticles for years through traditional anthropogenic sources, evidence shows that the exposure has dramatically increased in the last century. In this nano-age, are engineered nanoparticles better or worst than those we are accustomed to? What is being done to understand their impact on humans and the environment? Tremendous efforts are ongoing worldwide to increase our understanding of this subject. Join us for this provocative session and hear what the experts have to say and what has been learned so far.

To borrow a phrase, “Wake Up and Smell the IP”, IP management and protection has become one of the hottest issues in corporate America due to Sarbanes-Oxley. Nanotechnology patent applications rank as the fastest growing category in the US Patents and Trademark Office (USPTO) and the backlog is at it’s highest in its history. How do these trends relate to each other? How do they impact: Inventors wanting to protect their inventions; Entrepreneurs wanting to start a new company; or Large company exec wanting to acquire new technologies? Most often, the make or break for success will depend on how well you covered your bases. Join us to learn valuable and practical insights on the realities and risks associated with existing processes, business and acquisition trends and legal frameworks and what you can do to mitigate your risks.

Pharmaceutical scientists expend much effort in finding ways to selectively target therapeutics because, each year, billions are spent on pharmaceuticals with poor bio-availability which not only results in higher patient costs and inefficient treatments, but also in increased risks of toxicity and even death. Nano-enabled drug delivery may eliminate the pharmacokinetic difficulties because of its potential to better deliver drugs to defined areas and permeate through cell walls, facilitate solubility, and prevent rapid breakdown and/or clearance of drugs in vivo. Come join us to hear the highlights of the major nano-enabled drug delivery technologies that are commercially available or under development.

What does it take to create and operate a successful nanotech company in today’s competitive landscape? How is the journey of a nanotechnology entrepreneur different from or similar to the path of a conventional technology start-up? These and many other questions will be pondered by a distinguished panel of nanotechnology executives, veteran entrepreneurs, venture capitalists, and financiers. Discussion topics will include sources of technology acquisition and early stage funding, typical exit strategies for a nanotechnology start-up, alternative financing models, anticipated industry trends, and many more. Program will be preceded and followed by a lively reception with ample opportunity to network.

The National Cancer Institute (NCI) set aside $144 million in 2004 for the creation of eight centers of cancer nanotechnology excellence with steep mandates and complex requirements. Join us to learn how this novel approach will help impact the chances of success in the fight against cancer. San Diego-based NanoTumor Center leaders will share the progress on top research projects and plans for commercialization.

Canada has been at the forefront of Nanotechnology Research and Development for years. Significant investment for the development of infrastructure is the hallmark of strategic initiatives in place across regions like Alberta, British Columbia, Ontario and Quebec. Join us to learn about these innovative programs and models for collaboration and commercialization and what this can mean to companies and researchers worldwide.

Join us for an evening of networking and help us celebrate the second anniversary of the NanoBioNexus organization. This will be an excellent opportunity to spend some quality time and get to know other thought-leaders from the business and scientific communities that are interested in cutting-edge nanosciences.

This year is expected to be the first in which the money put into nanotechnology R&D globally by industry will exceed that coming from government. What does this mean for investors? Where and what are the nanotech investment opportunities today? A panel of experts will share their insights into the nanotech investment arena.

Although some of the applications for nanomedicine are quite futuristic, others are on the verge of generating significant revenues. Nanotherapeutics involves the treatment of disease using techniques and technologies developed at the nanoscale. Join us to learn how nanotherapeutics and molecular imaging will help lead to better methods of studying biological processes and manage diseases.

This seminar is focused on creating nanoscale architectures through molecular recognition and self-assembly. How will this impact nanotechnology applications and what is the significance of self-assembled structures?

The FDA expects that many of the nanotechnology products will span the regulatory boundaries between drugs, medical devices and biologicals. Learn how these and other issues around policy and public perception are being addressed. Is the chemical characterization of nanoscale materials available today complete? Are traditional approaches and study protocols sufficiently robust to do the job?

With an incredible amount of government and industry funding for nanotechnology innovations, entrepreneurs and inventors can capitalize on commercialization opportunities like never before. If it sounds easy, think again. Join us for an eye-opening discussion on the defining realities and risks associated with this field that will determine success or failure for new ventures.

High patient costs, inefficient treatments and risks of toxicity or even death are putting immense pressures on pharmaceutical and biotech companies to produce a steady stream of affordable, yet innovative and well-differentiated drugs. Will nanotechnology be the means for improving drug discovery and drug delivery systems to create new profitable products for these companies?

You are cordially invited to join us for a networking reception celebrating the first year anniversary of NanoBioNexus organization. This will be an excellent opportunity to spend some quality time networking with business and scientific leaders.

Learn about the many innovative ways nanotechnology is being implemented for bioanalytical and diagnostic products. Will a new class of products and companies emerge and leapfrog the competition? How can these products improve drug discovery and what is the downstream impact on patient care?

Human repair can be accelerated significantly with the use of nanotechnology-enabled materials and the process of molecular recognition. Join us for a discussion on what it will take to manufacture these technologies. Are we up to the task to truly regenerate bone, vision, hearing or hair?

Join us for an educational segment on the history of nanobiotechnology and a lively discussion on where current breakthroughs take us as the New Year unfolds. What can we expect in the near term, three-to-five years, and beyond?

The application of nanotechnology to cancer research is particularly attractive for its potential to deliver innovative tools that can transform promising molecular discoveries into benefits for cancer patients. The National Cancer Institute recently announced a new $144.3 million, five-year initiative to support cancer research using nanotechnology. How will the latest NCI initiative accelerate progress in nanotech cancer programs?

When is nanotechnology ready to become a spinout and leave the research lab’s nest? What needs to be done to protect trade secrets and intellectual property? What will it take to succeed at the early stage, mid-stage and late-stage of a spinout’s life? Join us for an enlightening presentation from actual nanotech spinout companies and the institutions in place to enable nanotech commercialization.

A panel of experts share their methods for sifting through the hype and misinformation about nanotechnology in the life sciences. A planned cross section of perspectives was chosen for this event. They include investment, commercialization, legal and academic.